Glial relay in hypothalamus links blood sugar to appetite suppression

When researchers gently dripped glucose onto a single cell deep in a rodent hypothalamus, nearby brain cells lit up in a coordinated wave. That unexpected response, described in a study published April 6 in Proceedings of the National Academy of Sciences, outlines a previously unrecognized circuit for appetite control that puts glial cells — long considered supporting actors — at center stage.

A glia-to-glia-to-neuron relay

The teams at the University of Concepción in Chile and the University of Maryland report that tanycytes, a specialized class of glial cells that line the brain’s third ventricle, detect rising glucose and release lactate. Neighboring astrocytes sense that lactate through the receptor HCAR1 (also called GPR81) and respond by releasing glutamate, an excitatory neurotransmitter. That glutamate strengthens excitatory input onto pro-opiomelanocortin (POMC) neurons in the arcuate nucleus — a population well known to suppress appetite when activated.

By placing tanycytes and astrocytes into a single signaling chain, the study shifts part of the focus in appetite research away from neurons alone and toward how glial cells and metabolic signals interact to shape feeding circuits.

“People tend to immediately think of neurons when they think about how the brain works,” said Ricardo C. Araneda, a professor of biology at the University of Maryland and a senior author on the paper, in a university news release. The new data, he added, highlight astrocytes as an essential intermediary in nutrient sensing.

How the researchers showed the connection

The authors used targeted stimulation, live imaging and electrophysiology in rodent tissue to build the mechanistic case. They locally increased glucose near individual tanycytes and monitored calcium signals in adjacent astrocytes, observing activity that spread through the local network. They showed the presence of HCAR1 on astrocytes in the region and found that applying lactate or a selective HCAR1 agonist activated astrocytes and triggered glutamate release.

Recordings from POMC neurons in brain slices indicated the astrocyte activity translated to stronger glutamatergic input and increased neuronal excitability, consistent with a pathway that could dampen appetite.

What the study does — and does not — show

The paper focuses on mechanistic links at cellular and circuit levels rather than on whole‑animal feeding behavior. University press materials note the work was done in animal models and outline plans to test whether manipulating astrocyte HCAR1 alters food intake. Large‑scale behavioral studies measuring changes in feeding and body weight after targeted interventions were not reported in the PNAS paper.

That distinction is important for interpreting translational potential. While the pathway points to an astrocyte receptor that could, in theory, be targeted to influence appetite, HCAR1 (GPR81) is widely expressed in brain and peripheral tissues and responds to lactate — a ubiquitous metabolic molecule. Systemically modulating this receptor could produce effects beyond feeding.

Moreover, the experiments were performed in rodents. Although tanycytes and astrocytes exist in the human hypothalamus, the wiring and physiological roles of these cells can differ across species. Whether HCAR1 in human astrocytes plays the same role in appetite regulation remains unknown.

Context: where this fits in appetite research

The study arrives amid intense interest in new ways to influence appetite. Globally rising obesity rates and the rapid adoption of drugs that act on gut‑brain hormone signaling — such as GLP‑1 receptor agonists like semaglutide (marketed as Ozempic and Wegovy) — have shown the profound impact of targeting brain responses to metabolic signals. The pathway described here is distinct: it centers on how the hypothalamus senses circulating nutrients and routes that information through glial signaling rather than through neuronal hormone receptors alone.

Within basic neuroscience, the findings add to a broader reevaluation of glial roles. Once labeled passive support cells, glia are increasingly implicated in circuits that regulate memory, mood, sleep and now potentially satiety.

Next steps and implications

The authors, supported by Chile’s National Fund for Scientific and Technological Development, the Millennium Institute of Neuroscience in Valparaíso and the U.S. National Institutes of Health, say they plan to test whether directly tweaking HCAR1 in astrocytes changes feeding behavior in animals. If those behavioral studies show measurable effects on food intake and body weight, they could begin to translate cellular signaling diagrams into potential therapeutic strategies — though any clinical application remains years away.

For now, the main impact of the work is conceptual: it suggests that the brain’s response to a rise in blood sugar may depend not only on neurons but on a choreography between different glial cell types and a receptor tuned to a common metabolic byproduct. Mapping that choreography more fully could help explain why appetite is so difficult to control and may point to new, more specific ways to modulate it in the future.